Navigation Links
BlackArch Partners Advises PCI Synthesis on Sale to Novacap SAS
Date:7/22/2018

BlackArch Partners LLC (“BlackArch”) is pleased to announce the sale of PCI Synthesis (“PCI” or the “Company”), to Novacap SAS (“Novacap”).

PCI Synthesis (https://www.pcisynthesis.com), headquartered in Newburyport, MA, is a leading contract developer and manufacturer (“CDMO”) of active pharmaceutical ingredients (“APIs”). The Company maintains a full range of API development and manufacturing services for small molecule new chemical entities and niche generic APIs and is uniquely positioned to deliver end-to-end process research and development through commercial scale manufacturing. PCI serves a diverse base of small, mid-size and large global innovator and generic pharmaceutical customers from more than ~75,000 sq. ft. of facilities that are local to Boston, one of the largest and most innovative pharmaceutical hubs in the United States.

The Company has experienced double-digit growth for the past five years and has expanded its capabilities to include GMP manufacturing of nutraceuticals and pharma foods, large-scale cryogenic manufacturing, large-scale chromatography, controlled substance development and medical-grade polymers. PCI’s premier services have earned them numerous awards and recognition as being a top performer amongst its CDMO peers.

Ed Price, the CEO and founder of PCI Synthesis commented: “BlackArch truly understands our business and industry. Their guidance in terms of positioning PCI strategically, operationally and financially to buyers was invaluable and resulted in an exceptional outcome for our Company. They worked tirelessly to execute and close this transaction while securing an ideal partner we are excited to work with.”

BlackArch was retained by PCI synthesis to serve as its exclusive financial advisor given BlackArch’s depth of experience and global reach in the pharmaceutical services sector.

Transaction Highlights

  • After a highly efficient and global sale process PCI agreed to be acquired by Novacap
  • PCI, the first acquisition by Novacap in the U.S., will be Novacap’s lead U.S. company and the combination provides PCI Synthesis with additional resources to continue its development while reinforcing Novacap’s global leadership in pharmaceutical synthesis
  • BlackArch leveraged its deep end market and business knowledge in pharmaceutical services to achieve a superior outcome for the Company and its shareholders

About PCI Synthesis
PCI Synthesis is a Pharmaceutical Development CDMO (Contract Development and Manufacturing Organization) based in Newburyport, Mass. and is the largest small molecule drug substance manufacturer in the New England area. A wholly-owned subsidiary of Novacap, PCI Synthesis is also a commercial manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and other specialty chemical products for the medical device industry. As a CDMO, PCI Synthesis provides emerging and mid-sized pharmaceutical companies access to the expertise needed to develop and manufacture complex small molecules.

About Novacap
Novacap is a global player in pharmaceutical synthesis, advanced specialties and cosmetics. The Group offers its clients custom manufacturing services for pharmaceutical and speciality markets as well as a large portfolio of APIs & pharmaceutical intermediates. Novacap also boasts leading positions in a variety of markets, including cosmetics and fragrances, electronics, home care, food and feed or environment. Novacap sets itself apart not only by the outstanding quality of its products but also by its culture of excellence which aims at providing its clients with the best level of service. Novacap posted sales of $1bn in 2017, operates 28 industrial plants and employs more than 3,000 people across the world.

About BlackArch Partners
BlackArch Partners is a leading middle-market investment bank offering a full spectrum of advisory services to financial sponsors, private companies and diversified corporations. BlackArch addresses the needs of owner-operators, founders and shareholders of private companies with specialized services that include M&A advisory, strategic advisory and private capital solutions. Headquartered in Charlotte, North Carolina, with offices in New York, New York, Chicago, Illinois and Houston, Texas, BlackArch features a total of 12 industry-focused practices that cover all sectors of interest to middle-market investors; BlackArch professionals have closed more than 350 transactions in 16 countries on 4 continents. For more information, visit http://www.blackarchpartners.com.

Securities offered through BlackArch Securities LLC. Member FINRA and SIPC. Testimonials may not be representative of the experience of all clients. Testimonials are not a guarantee of future performance or success.

Read the full story at https://www.prweb.com/releases/blackarch_partners_advises_pci_synthesis_on_sale_to_novacap_sas/prweb15640268.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related medicine news :

1. Allegheny Health Network Partners with Region’s EMS Providers to Advance Treatment of Heart Attack Patients
2. Yogafit Partners With Wholebeing Institute, Bringing Positive Psychology Into Yoga Therapy Training
3. BeachLifestyle and The Total Education Network Announce Their Partnership as the Simply G Media Network
4. Maine Biotechnology Services-USDA-ARS Partnership Provides Monoclonal Antibodies to Aid in the Containment of Rift Valley Fever Virus
5. Tunstall Americas Partners with Faith Tele-health dba Concierge Care Transition to Pilot New Transitional Care Service
6. Zamzee® Partners with Safe Routes to School™ Initiative in West Coast Communities
7. Humility of Mary Health Partners Names Kathy Cook New President of St. Joseph Health Center
8. PolyU Gears Up for Aviation Services Research in Partnership with Boeing
9. U.S.-based Children’s Medical Charity Mobilizes Global Partners Aiding Operation Smile’s Philippine Foundation Post-Typhoon
10. National MS Society partners with Accelerated Cure Project Online Forum to drive progress
11. Zing Partners LLC Announces US Patent and Trademark Office Approval of Zippy Soother Design Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/8/2019)... (PRWEB) , ... October 08, 2019 , ... METAvivor Research ... breast cancer, announced the launch of its Stage IV Stampede campaign. The campaign will ... in Washington, DC that will include an advocacy boot camp, a march, a Die-In ...
(Date:10/8/2019)... ... October 08, 2019 , ... Dr. ... has recently attended an advanced Level III training in Cagliari, Italy, this past ... training took place September 16-19, 2019 at the Sardinia Dental Teaching Center and ...
(Date:10/8/2019)... , ... October 08, 2019 , ... ... headquartered in Irving, Texas, that exclusively serves premier oral and maxillofacial surgeons – ... oral and maxillofacial surgery practice with two locations near Knoxville, Tennessee. The partnership ...
(Date:10/8/2019)... ... 08, 2019 , ... Continuing its leading research on human ... Care4U™ 2’-FL, a DuPont product, beneficially changes microbiota composition and the production of ... microbiota and metabolite composition by 2’-FL were between the responses elicited by GOS ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... is pleased to announce the addition of Brenda Thomas, an industry professional with ... Account Manager for the Professional Services Plans dental team at Brown & Brown ...
Breaking Medicine News(10 mins):
(Date:10/8/2019)... ... October 08, 2019 , ... For many Americans, dental insurance is limited ... paid out of pocket. Yearly insurance payouts are generally capped at around $1,500—which doesn’t ... million people who are 65 or older. (Standard Medicare does not cover any dental ...
(Date:10/8/2019)... ... ... A free, interactive event highlighting innovations and ideas helping people with Parkinson’s live ... innovators and health experts, will display innovations that could help people with Parkinson’s disease ... on October 19 at the Coppertank Event Center in Austin, the event is co-hosted ...
(Date:10/8/2019)... ... 08, 2019 , ... Dr. Dorette Noorhasan offers a unique ... Fertility Doctor’s Fight for Motherhood (Brown Books Publishing Group), which releases today, October ... encourage, advise and support people who want to bring a new life into ...
Breaking Medicine Technology: